Related references
Note: Only part of the references are listed.The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection
Maria-Luisa Del Rio et al.
TRANSLATIONAL RESEARCH (2022)
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model
Jose-Ignacio Rodriguez-Barbosa et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion
Maite Alvarez et al.
FRONTIERS IN IMMUNOLOGY (2020)
Programmed cell death protein 1 on natural killer cells: fact or fiction?
Monica M. Cho et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Minimal PD-1 expression in mouse and human NK cells under diverse conditions
Sean J. Judge et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
Cai Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis
Rui Sun et al.
TRANSLATIONAL ONCOLOGY (2020)
The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
Linda Quatrini et al.
CANCERS (2020)
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Tao Gong et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses
Daisuke Sugiura et al.
SCIENCE (2019)
Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
Huizhong Xiong et al.
CANCER IMMUNOLOGY RESEARCH (2019)
The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector
Wenjuan Dong et al.
CANCER DISCOVERY (2019)
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
Silvia Pesce et al.
FRONTIERS IN IMMUNOLOGY (2019)
Hybrid resistance to parental bone marrow grafts in nonlethally irradiated mice
Benedikt Mahr et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways
Yunlong Zhao et al.
IMMUNITY (2019)
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression!
Francesca R. Mariotti et al.
ONCOIMMUNOLOGY (2019)
The bone marrow is not only a primary lymphoid organ: The critical role for T lymphocyte migration and housing of long-term memory plasma cells
Reinhard Pabst
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface
Apoorvi Chaudhri et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
NK cells for PD-1/PD-L1 blockade immunotherapy: pinning down the NK cell
Cordelia Dunai et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
PD-L1 blockade enhances anti-tumor efficacy of NK cells
Jeremiah L. Oyer et al.
ONCOIMMUNOLOGY (2018)
T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway
Jose-Ignacio Rodriguez-Barbosa et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Control of NK Cell Activation by Immune Checkpoint Molecules
Asma Beldi-Ferchiou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier
Maria-Luisa Del Rio et al.
TRANSLATIONAL RESEARCH (2017)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt et al.
IMMUNITY (2016)
NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells
Ximena L. Raffo Iraolagoitia et al.
JOURNAL OF IMMUNOLOGY (2016)
Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells
Maria-Luisa del Rio et al.
MABS (2016)
PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells
Yanan Guo et al.
ONCOTARGET (2016)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
Ines Pires da Silva et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Cis-trans interactions of cell surface receptors: biological roles and structural basis
Werner Held et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M. Benson et al.
BLOOD (2010)
The Rap GTPases regulate the migration, invasiveness and in vivo dissemination of B-cell lymphomas
K. B. L. Lin et al.
ONCOGENE (2010)
Macrophages as mediators of tumor immunosurveillance
Siddhartha Jaiswal et al.
TRENDS IN IMMUNOLOGY (2010)
NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism
K. Hamby et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
The natural history of a novel, systemic, disseminated model of syngeneic mouse B-cell lymphoma
MJ Passineau et al.
LEUKEMIA & LYMPHOMA (2005)
Expression of programmed death 1 ligands by murine T cells and APC
T Yamazaki et al.
JOURNAL OF IMMUNOLOGY (2002)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants
S Goddard et al.
TRANSPLANTATION (2001)
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
H Nishimura et al.
SCIENCE (2001)
Share Paper
